Type of securities : Common share | Effective Date : 06/10/2023 | Close Selling Date : 12/10/2023
Ref. WINNER 0009/20108 Page 1 of 10 Disclosures on the asset acquisition of Winner Group Enterprise Public Company Limited on share purchase of Aesthetic Zecret (At-Ze) Company Limited (Schedule 1
Ref. WINNER 0009/20108 Page 1 of 8 Disclosures on the asset acquisition of Winner Group Enterprise Public Company Limited on share purchase of Aesthetic Zecret (At-Ze) Company Limited (Schedule 1
Ref. WINNER 0009/20108 Page 1 of 8 - Translation - Ref. WINNER 0009/2018 February 28, 2018 Re Information Memorandum on Acquiring of Ordinary Shares in Aesthetic Zecret (At-Ze) Co., Ltd. To The
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic
increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost
. Analysis of Overall Operating Results for the Company and its subsidiary 1.1 Important circumstance during the year In April 2018, the Company acquired 800,000 ordinary shares of Aesthetic Zecret (AT-ZE
Thailand 1. Analysis of Overall Operating Results for the Company and its subsidiary 1.1 Important circumstance during the year In April 2018, the Company acquired 800,000 ordinary shares of Aesthetic Zecret